Angiotensin Type 2 Receptor (AT2R): A Challenging Twin (Q35122620)

6 August 2017

1 reference

title

Angiotensin type 2 receptor (AT2R): a challenging twin (English)

1 reference

6 August 2017

Angiotensin Type 2 Receptor (AT2R): A Challenging Twin (English)

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.181.PE16

31 December 2023

author name string

Bradford C. Berk

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734384

31 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12734384

31 December 2023

publication date

6 May 2003

1 reference

full work available at URL

6 August 2017

https://syndication.highwire.org/content/doi/10.1126/stke.2003.181.pe16

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.181.PE16

Science's STKE : signal transduction knowledge environment

31 December 2023

published in

1 reference

6 August 2017

volume

2003

1 reference

6 August 2017

issue

181

1 reference

6 August 2017

page(s)

PE16

1 reference

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.181.PE16

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.181.PE16

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.181.PE16

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.181.PE16

Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.181.PE16

The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.181.PE16

Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.181.PE16

Gbeta gamma -independent constitutive association of Galpha s with SHP-1 and angiotensin II receptor AT2 is essential in AT2-mediated ITIM-independent activation of SHP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.181.PE16

The angiotensin II AT2 receptor is an AT1 receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.181.PE16

Nitric oxide and cyclic GMP are involved in angiotensin II AT(2) receptor effects on neurite outgrowth in NG108-15 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.181.PE16

Ligand-independent signals from angiotensin II type 2 receptor induce apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.181.PE16

Constitutive activation of angiotensin II type 1 receptor alters the orientation of transmembrane Helix-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.181.PE16

Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.181.PE16

Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.181.PE16

AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.181.PE16

Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.181.PE16

Identification of a domain in the angiotensin II type 1 receptor determining Gq coupling by the use of receptor chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.181.PE16

The active state of the AT1 angiotensin receptor is generated by angiotensin II induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSTKE.2003.181.PE16

Inflammation influences vascular remodeling through AT2 receptor expression and signaling

21 January 2018

series ordinal

5

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.181.PE16

Journal of Biological Chemistry

31 December 2023

15

278

3606

2002

1 reference

https://api.crossref.org/works/10.1126/STKE.2003.181.PE16

31 December 2023

Identifiers

1 reference

6 August 2017

1 reference